Last updated on November 2019

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

Brief description of study

Primary Objective:

To determine the efficacy of SAR442168 in reducing the number of new brain lesions reported in Magnetic Resonance Imaging (MRI)

Secondary Objectives:

  • To evaluate the efficacy of SAR442168 on clinical symptoms and imaging measures
  • To evaluate the safety and tolerability of SAR442168

Detailed Study Description

The total study duration is 24 weeks which includes a screening period of 4 weeks, a treatment period of 16 weeks and a follow-up period of up to 4 weeks. Participants completing the Week 16 visit will be proposed to enroll in a long-term safety (LTS) follow-up study to assess safety and tolerability of SAR442168.

Clinical Study Identifier: NCT03889639

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.